Condensed Consolidated and Combined Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income (loss)	$ 5,031	$ (8,773)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	17,093	17,631
Amortization of deferred financing costs and debt discount	1,649	1,050
Write-off of deferred financing costs	1,208	0
Amortization of stock-based compensation	1,095	0
Noncash interest income adjustments	(697)	0
Loss on extinguishment of debt	0	1,998
Loss on settlement of interest rate swap	0	1,661
Change in operating assets and liabilities:
Accounts receivable	(2,945)	(10)
Accounts receivable due from related party	2,275	(2,876)
Prepaid expenses and other assets	(90)	387
Interest rate swap	0	(1,661)
Accounts payable and accrued liabilities	4,416	7,944
Net cash provided by operating activities	29,035	17,351
Cash flows from investing activities:
Acquisition of real estate	(231,501)	0
Improvements to real estate	(143)	(254)
Purchases of equipment, furniture and fixtures	(256)	(19,079)
Net proceeds from the sale of vacant land	30	0
Net cash used in investing activities	(231,870)	(19,333)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	163,466	0
Proceeds from the issuance of senior unsecured notes payable	0	260,000
Borrowings under unsecured credit facility	45,000	0
Borrowings under senior secured revolving credit facility	35,000	10,000
Proceeds from the issuance of mortgage notes payable	0	50,676
Repayments of borrowings under senior secured revolving credit facility	(35,000)	(88,701)
Payments on the mortgage notes payable	(2,509)	(67,493)
Payments on senior secured term loan	0	(65,624)
Payments of deferred financing costs	(2,113)	(13,282)
Net-settle adjustment on restricted stock	(145)	0
Dividends paid on common stock	(14,086)	0
Net contribution from Ensign	0	4,356
Net cash provided by financing activities	189,613	89,932
Net (decrease) increase in cash and cash equivalents	(13,222)	87,950
Cash and cash equivalents beginning of period	25,320	895
Cash and cash equivalents end of period	12,098	88,845
Supplemental disclosures of cash flow information:
Interest paid	12,338	8,004
Income taxes paid	0	104
Supplemental schedule of noncash operating, investing and financing activities:
Increase in dividends payable	3,758	0
Increase in offering costs payable	503	0
Application of escrow deposit to acquisition of real estate	500	0
Operating assets and liabilities that were not transferred to CareTrust	0	1,042
Equipment, furniture and fixtures that were not transferred to CareTrust	0	(11,684)
Net capital distribution to Ensign	$ 0	$ 10,475